The cumulative unbound drug concentration of REG, M-2, M-4, and M-5 estimated from their maximal tumor concentrations is well above the in vitro IC50 both in plasma and in tumor tissue, which should enable CSF1R inhibition in vivo. The gene discussed is CSF1R; the disease is neoplasm.